| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10485072 | Value in Health | 2012 | 10 Pages |
Abstract
In cost-utility analyses, the choice of quality-adjusted life-year measure may affect whether an intervention is considered cost-effective. Furthermore, if decisions are to be based on values from the general public, HUI-3 can be recommended for cost-utility analyses of interventions directed at diabetic retinopathy.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Emelie MSc, Ann-Britt PhD, Beatrice Bourghardt MD, Ulf MD, Lars-Ã
ke PhD,